Glibenclamide Supplier-Buyer Network — Trade Flow Analysis

Name: Glibenclamide Supplier-Buyer Trade Network Dataset — 194+ Indian Exporters, 13+ Importers, 100+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Glibenclamide supplier network, Glibenclamide buyers, pharmaceutical export India, Glibenclamide trade data

TransData Nexus

Glibenclamide

India Pharmaceutical Trade Intelligence

$41.2M194 Suppliers100 CountriesHS 30049099

ExportsIndia → SRI LANKA89.8%India → TANZANIA1.6%

ImportsGERMANY → India$20.1K UNITED STATES → India$817

#1 Supplier: MEDOPHARM #1 Buyer: A,BAUR &

Who Supplies Glibenclamide? Top Manufacturers & Buyers 2026 — MEDOPHARM Leads | TransData Nexus | TransData Nexus

1MEDOPHARM

MEDOPHARM is the first-largest Glibenclamide exporter from India, with a market share of 89.7% and a total export value of $37.0M across 48 shipments. Their average shipment value of $770.4K is above the market average of $44.3K, suggesting premium or bulk contract pricing.

MEDOPHARM serves 1 named buyer in our database. A,BAUR & CO,(PVT,) LTD is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• A,BAUR & CO,(PVT,) LTD — $37.0M across 48 shipments (100.0% of this supplier's total exports)

Key Insight: MEDOPHARM's per-shipment value of $770.4K is 1639% above the market average of $44.3K, consistent with large-order contracts or value-added formulations.

2CAPLIN POINT LABORATORIES LIMITED

CAPLIN POINT LABORATORIES LIMITED is the second-largest Glibenclamide exporter from India, with a market share of 0.6% and a total export value of $254.2K across 17 shipments. Their average shipment value of $15.0K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.

CAPLIN POINT LABORATORIES LIMITED serves 1 named buyer in our database. XXSSIXXPHAXXA AXX VX is the dominant customer, accounting for 100.0% of this supplier's tracked business. Top customers include:

• XXSSIXXPHAXXA AXX VX — $254.2K across 17 shipments (100.0% of this supplier's total exports)

Key Insight: CAPLIN POINT LABORATORIES LIMITED operates with high shipment frequency (17 shipments) at a per-shipment value of $15.0K, indicating a broad distribution network with many smaller, regular orders.

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the third-largest Glibenclamide exporter from India, with a market share of 0.6% and a total export value of $251.1K across 9 shipments. Their average shipment value of $27.9K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 3 named buyers in our database. PJSC PHARMSTANDARD-TOMSKHIMPHARM is the dominant customer, accounting for 73.2% of this supplier's tracked business. Top customers include:

• PJSC PHARMSTANDARD-TOMSKHIMPHARM — $183.7K across 7 shipments (73.2% of this supplier's total exports)

• PJSC PHARMSTANDARD-TOMSKHIMPHARM — $63.3K across 2 shipments (25.2% of this supplier's total exports)

• PHARMA VISION (PTY) — $4.1K across 0 shipments (1.6% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED operates with high shipment frequency (9 shipments) at a per-shipment value of $27.9K, indicating a broad distribution network with many smaller, regular orders.

4LINCOLN PHARMACEUTICALS LTD

LINCOLN PHARMACEUTICALS LTD is the fourth-largest Glibenclamide exporter from India, with a market share of 0.4% and a total export value of $184.4K across 16 shipments. Their average shipment value of $11.5K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.

LINCOLN PHARMACEUTICALS LTD serves 4 named buyers in our database. OPHAM is the dominant customer, accounting for 82.6% of this supplier's tracked business. Top customers include:

• OPHAM — $152.3K across 13 shipments (82.6% of this supplier's total exports)

• SOMAPHAR SA — $24.1K across 2 shipments (13.1% of this supplier's total exports)

• OPHAM ANDRIAMAHAZO B — $5.3K across 0 shipments (2.9% of this supplier's total exports)

• OPHAM ROUTE DIGUE AN — $2.6K across 0 shipments (1.4% of this supplier's total exports)

Key Insight: LINCOLN PHARMACEUTICALS LTD operates with high shipment frequency (16 shipments) at a per-shipment value of $11.5K, indicating a broad distribution network with many smaller, regular orders.

5M. J. BIOPHARM PRIVATE LIMITED

M. J. BIOPHARM PRIVATE LIMITED is the fifth-largest Glibenclamide exporter from India, with a market share of 0.3% and a total export value of $143.0K across 10 shipments. Their average shipment value of $14.3K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.

M. J. BIOPHARM PRIVATE LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• UNDP ZAMBIA — $38.7K across 3 shipments (27.1% of this supplier's total exports)

• U.N.R.W.A. UNITED NA — $36.8K across 3 shipments (25.7% of this supplier's total exports)

• IMRES — $29.8K across 2 shipments (20.8% of this supplier's total exports)

• UNITED NATIONS RELIE — $18.9K across 1 shipments (13.2% of this supplier's total exports)

• MOPO TSYO-PATIENT IN — $18.9K across 1 shipments (13.2% of this supplier's total exports)

Key Insight: M. J. BIOPHARM PRIVATE LIMITED operates with high shipment frequency (10 shipments) at a per-shipment value of $14.3K, indicating a broad distribution network with many smaller, regular orders.

6CIPLA LIMITED

CIPLA LIMITED is the fifth-largest Glibenclamide exporter from India, with a market share of 0.3% and a total export value of $132.2K across 27 shipments. Their average shipment value of $4.9K is below the market average of $44.3K, reflecting a high-volume, competitive pricing strategy.

CIPLA LIMITED serves 3 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• TO THE ORDER — $63.1K across 13 shipments (47.7% of this supplier's total exports)

• NA — $44.6K across 9 shipments (33.7% of this supplier's total exports)

• TO THE ORDER OF — $24.5K across 5 shipments (18.5% of this supplier's total exports)

Key Insight: CIPLA LIMITED operates with high shipment frequency (27 shipments) at a per-shipment value of $4.9K, indicating a broad distribution network with many smaller, regular orders.

1Sri Lanka

Sri Lanka ranks as the first-largest destination for Glibenclamide imports from India, with a total trade value of $37.0M across 2 shipments — representing a 89.8% share of all Glibenclamide exports. The average shipment value of $18.5M is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Glibenclamide importers in Sri Lanka: A,BAUR & CO,(PVT,) LTD is the largest buyer, accounting for 100.0% ($37.0M) of this market's total imports.

• A,BAUR & CO,(PVT,) LTD — $37.0M (100.0% of Sri Lanka's total)

Key Insight: Sri Lanka's per-shipment average of $18.5M (41639% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Sri Lanka is a key market for Glibenclamide imports from India.

Primary Market

Secondary Market

2Tanzania

Tanzania ranks as the second-largest destination for Glibenclamide imports from India, with a total trade value of $656.4K across 4 shipments — representing a 1.6% share of all Glibenclamide exports. The average shipment value of $164.1K is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Glibenclamide importers in Tanzania: HEKO PHARMACY LTD is the largest buyer, accounting for 8.2% ($54.1K) of this market's total imports.

• HEKO PHARMACY LTD — $54.1K (8.2% of Tanzania's total)

Key Insight: Tanzania's per-shipment average of $164.1K (270% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Tanzania is a key market for Glibenclamide imports from India.

Primary Market

Secondary Market

3Russia

Russia ranks as the third-largest destination for Glibenclamide imports from India, with a total trade value of $475.8K across 7 shipments — representing a 1.2% share of all Glibenclamide exports. The average shipment value of $68.0K is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Glibenclamide importers in Russia: PJSC PHARMSTANDARD-TOMSKHIMPHARM is the largest buyer, accounting for 38.6% ($183.7K) of this market's total imports.

• PJSC PHARMSTANDARD-TOMSKHIMPHARM — $183.7K (38.6% of Russia's total)

• PJSC "PHARMSTANDARD-TOMSKHIMPHARM" — $116.3K (24.4% of Russia's total)

Key Insight: Russia's per-shipment average of $68.0K (53% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Glibenclamide imports from India.

Primary Market

Secondary Market

4South Africa

South Africa ranks as the fourth-largest destination for Glibenclamide imports from India, with a total trade value of $469.0K across 25 shipments — representing a 1.1% share of all Glibenclamide exports. The average shipment value of $18.8K is below the global average of $44.3K, consistent with generic/API volume purchasing. This market is served by 5 tracked buyers.

Named Glibenclamide importers in South Africa: OETHMAAN BIOSIMS PTY LIMITED is the largest buyer, accounting for 24.4% ($114.5K) of this market's total imports.

• OETHMAAN BIOSIMS PTY LIMITED — $114.5K (24.4% of South Africa's total)

• BIOTECH LABORATORIES (PTY) LTD — $81.1K (17.3% of South Africa's total)

• OETHMAAN BIOSIMS PTY LTD — $69.2K (14.8% of South Africa's total)

Key Insight: South Africa receives frequent, smaller shipments of Glibenclamide — typical of markets with distributed retail pharmacy or hospital networks sourcing generics at volume.

South Africa is a key market for Glibenclamide imports from India.

Primary Market

Secondary Market

5Cambodia

Cambodia ranks as the fifth-largest destination for Glibenclamide imports from India, with a total trade value of $285.8K across 0 shipments — representing a 0.7% share of all Glibenclamide exports. The average shipment value of $285.8K is above the global average of $44.3K, indicating high-value procurement contracts or branded formulations.

Key Insight: Cambodia's per-shipment average of $285.8K (545% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Cambodia is a key market for Glibenclamide imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Glibenclamide.
2.Flow Mapping: 194 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 930 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 100 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

930 Verified Shipments

194 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Glibenclamide

Glibenclamide

Who Supplies Glibenclamide? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Glibenclamide? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Glibenclamide Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1MEDOPHARM

2CAPLIN POINT LABORATORIES LIMITED

3SUN PHARMACEUTICAL INDUSTRIES LIMITED

4LINCOLN PHARMACEUTICALS LTD

5M. J. BIOPHARM PRIVATE LIMITED

6CIPLA LIMITED

From Indian Factories to Global Pharmacies — How Glibenclamide Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Glibenclamide Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1Sri Lanka

2Tanzania

3Russia

4South Africa

5Cambodia

People Also Ask — Glibenclamide Supplier & Trade Network

Glibenclamide Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology